hand in blue latex glove holding a test tube

News & Press Releases

With our LIMS configurable technology and workflow
templates, projects are completed in a fraction of the
time and cost
of standard LIMS projects.

Posted: July 30, 2018

Sapio Sciences LLC is pleased to announce that GeneCentric Therapeutics Inc has selected Exemplar ELN Professional as its LIMS/ELN Platform. Exemplar ELN Professional is the most feature rich relea ... Read More

Posted: March 8, 2018

Baltimore, MD – March 7, 2018 –Sapio Sciences LLC is pleased to announce the release of Exemplar LIMS/ELN X, the most feature rich release in Sapio’s history, including features to enab ... Read More

Posted: February 24, 2018

York, PA – February 24, 2018 – Kevin Cramer, CEO of Sapio Sciences has announced the installations of ~15KW solar array on the roof of Sapio’s York, Pennsylvania facility.   As an inc ... Read More

Posted: December 23, 2017

Sapio is pleased to add another Cambridge Biotech company to its strong portfolio of companies in Boston metro area. This customer has an initial focus on materials management with expansion into full ... Read More

Schedule a Demonstration of Exemplar

We are happy to setup a time to demonstrate Exemplar.


We respect your privacy and do not tolerate spam and will never sell, rent, lease or give away your information (name, address, email, etc.) to any third party. Nor will we send you unsolicited email.

Latest resources

  • cover page of The Workflow Driven Lab whitepaper

    The Workflow Driven Lab

  • cover page of Exemplar Dx LIMS whitepaper

    Exemplar Dx LIMS

  • cover page of How To Buy a LIMS - The 5 Question RFP whitepaper

    How To Buy a LIMS - The 5 Question RFP

  • cover page of Exemplar LIMS for NGS Labs whitepaper

    Exemplar LIMS for NGS Labs

Access to our FREE resource area with white papers and insights, requires account registration.

We respect your privacy and do not tolerate spam and will never sell, rent, lease or give away your information (name, address, email, etc.) to any third party.